Dir
Joseph J. Wolk is the Executive Vice President and Chief Financial Officer of Johnson & Johnson, a position he has held since 2018[[1]](https://www.jnj.com/joseph-j-wolk). With over 26 years of tenure at the company, he leads the worldwide Finance and Global Services organizations comprising approximately 9,000 employees and serves as a member of the company's Executive Committee[[1]](https://www.jnj.com/joseph-j-wolk). As the financial steward of J&J, Wolk is responsible for developing and executing the company's global long-term financial strategy, driving competitive and profitable growth, generating sustainable cash flow, allocating capital to maximize value creation, and managing enterprise-wide risk[[1]](https://www.jnj.com/joseph-j-wolk).
Wolk holds a Bachelor of Science degree in Finance from St. Joseph's University and a Juris Doctor degree from Temple University School of Law; he is also a Certified Public Accountant[[2]](https://mitcfo.com/speakers/joseph-wolk/). Before becoming CFO, he served as Vice President of Investor Relations, where his team was recognized by *Institutional Investor* as among the best in the industry[[1]](https://www.jnj.com/joseph-j-wolk). Throughout his career at Johnson & Johnson, he has held senior leadership roles including Vice President of Finance for the Innovative Medicine Group, Vice President of Finance for MedTech's Global Supply Chain, and Chief Financial Officer of the North America Innovative Medicine Group[[1]](https://www.jnj.com/joseph-j-wolk). Beyond his primary role, Wolk serves on the Board of Directors of Prudential Financial, Inc., the Stanford Medicine Board of Fellows, the CNBC Global CFO Council, and the Wall Street Journal CFO Network[[1]](https://www.jnj.com/joseph-j-wolk). He is also the executive sponsor of Johnson & Johnson's Impact Venture Fund, which supports entrepreneurs and social enterprises addressing global healthcare challenges[[1]](https://www.jnj.com/joseph-j-wolk).
View full insider profile →
